Bromperidol: Difference between revisions
m Protected "Bromperidol": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
Kiran Singh (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| IUPAC_name = ''4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one'' | | IUPAC_name = ''4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one'' | ||
| image = | | image =Structure of bromperidol.png | ||
| width = 300 | | width = 300 | ||
| CAS_number = | | CAS_number = | ||
| Line 24: | Line 24: | ||
| routes_of_administration = Oral | | routes_of_administration = Oral | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Bromperidol''' is a [[drug]] which is a [[butyrophenone]] derivative. It is a potent and long-acting [[neuroleptic]], used as an [[antipsychotic]] in the treatment of [[schizophrenia]]. | '''Bromperidol''' is a [[drug]] which is a [[butyrophenone]] derivative. It is a potent and long-acting [[neuroleptic]], used as an [[antipsychotic]] in the treatment of [[schizophrenia]]. | ||
| Line 36: | Line 41: | ||
[[Category:Antipsychotics]] | [[Category:Antipsychotics]] | ||
[[Category:Drug]] | |||
{{psychoactive-stub}} | {{psychoactive-stub}} | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
Latest revision as of 13:02, 13 April 2015
 | |
| Clinical data | |
|---|---|
| Routes of administration | Oral |
| ATC code | |
| Identifiers | |
| |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H23BrFNO2 |
| Molar mass | 420.315 g/mol |
|
WikiDoc Resources for Bromperidol |
|
Articles |
|---|
|
Most recent articles on Bromperidol Most cited articles on Bromperidol |
|
Media |
|
Powerpoint slides on Bromperidol |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Bromperidol at Clinical Trials.gov Clinical Trials on Bromperidol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Bromperidol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Bromperidol Discussion groups on Bromperidol Patient Handouts on Bromperidol Directions to Hospitals Treating Bromperidol Risk calculators and risk factors for Bromperidol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Bromperidol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Bromperidol is a drug which is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia.
Bromperidol was discovered at Janssen Pharmaceutica in 1966.
See also
References
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Antipsychotics
- Drug